Indivior Pharmaceuticals, Inc. (INDV) Q4 2024 Annual Earnings
INDV·Reported February 20, 2025·Before market open
Indivior Pharmaceuticals, Inc. reported Q4 2024 revenue of $299.0M, beat analyst consensus of $240.1M by $58.9M. Diluted EPS came in at $0.32.
Revenue
$299.0Mbeat by $58.9M
Consensus: $240.1MDiluted EPS
$0.32met estimate
Consensus: $0.32
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Indivior Pharmaceuticals, Inc. 's Q4 2024 earnings report.
Indivior Pharmaceuticals, Inc. (INDV) reported Q4 2024 earnings on February 20, 2025 before market open.
Indivior Pharmaceuticals, Inc. reported revenue of $299.0M and diluted EPS of $0.32 for Q4 2024.
Revenue beat the consensus estimate of $240.1M by $58.9M. EPS beat the consensus estimate of $0.32 by $0.00.
You can read the 10-K periodic report (0001625297-25-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.